SCS Traditional denied as not FDA-approved for this use by eviCore healthcare?

NACC-aligned. Conservative therapy >=6 weeks, BHE clearance, >=50% trial relief documented for SCS implant.

Submit eviCore PA retroactively with full clinical. Psychologist letter explicitly stating 'appropriate candidate per NACC criteria.' Trial diary: daily NRS, ODI pre/post, analgesic reduction, patient global impression.

## Why eviCore Denied on FDA-Approval Grounds — and Why This Is Directly Rebuttable

A "not FDA-approved" denial for traditional (conventional, tonic) spinal cord stimulation is one of the most factually rebuttable denials you can receive. Conventional SCS devices have carried FDA clearance for decades. When eviCore issues this denial, it typically reflects one of three situations: (1) a clerical or coding error in the prior-authorization review, (2) the specific indication or diagnosis falls outside the language of the applicable clinical guideline even though the device itself is cleared, or (3) a specific programming parameter was flagged as investigational. Each of these situations has a distinct appeal strategy.

## Establishing the Regulatory Record

The FDA's 510(k) premarket notification database is publicly searchable. Before filing your appeal, confirm the clearance status of the specific device. Attach the clearance letter and the device's labeled indications to your appeal. This single step often resolves the denial at Level 1 by demonstrating the factual error.

## Your Federal Appeal Rights

Even if the denial is maintained internally, fully-insured ACA plan members have the right to external review under ACA §2719, which explicitly covers experimental/investigational and not-approved denials. External reviewers are independent and frequently reverse these denials when the device has FDA clearance. ERISA self-funded plan participants are entitled to full-and-fair review under ERISA §503. File for external review within four months of the final internal denial. Expedited review (72-hour turnaround) is available if the delay would harm your health.

## Appeal Timeline

1. Immediately file Level 1 internal appeal attaching the FDA clearance document. 2. Request peer-to-peer review between the implanting physician and eviCore's medical director. 3. File for external review as soon as the internal appeal is denied.

## Documentation to Gather

• FDA 510(k) clearance letter for the specific device and the labeled indications section from the manufacturer's Instructions for Use.
• Physician medical-necessity letter: states the diagnosis, explains why SCS is indicated, and references the cleared indication by name.
• Diagnosis and prior-treatment documentation: confirming the patient meets the cleared indication.
• Professional society support: the physician should cite the relevant professional society guideline organization to support established use for the diagnosis.

## Criteria-Mapping Structure

Obtain eviCore's clinical guideline for SCS. List each coverage criterion. For the FDA-approval criterion specifically, cite the clearance number and attach the clearance document. For all remaining criteria, map each to a specific chart fact. Lead the appeal letter with the FDA clearance rebuttal — it sets the factual tone for the entire submission.